Biodeal Pharmaceuticals

Piramal Alternatives invests $13.2 mn in contract drugmaker Biodeal

Piramal Alternatives, the fund management arm of the Piramal Group, has announced a Rs 110-crore ($13.2 million) ......

• Sreeja Biswas